Revel Pharmaceuticals的封面图片
Revel Pharmaceuticals

Revel Pharmaceuticals

生物技术研究

San Francisco,CA 1,959 位关注者

Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage.

关于我们

Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage. We are targeting pathological, age associated compounds known as Advanced Glycation End Products (AGEs) which build up on long lived proteins like collagen. AGE accumulation is implicated in multiple diseases of aging, thus Revel Pharmaceuticals is strategically positioned to develop therapeutics across multiple indications.

网站
https://revelpharmaceuticals.com
所属行业
生物技术研究
规模
2-10 人
总部
San Francisco,CA
类型
私人持股
创立
2019

地点

  • 主要

    953 Indiana Street

    US,CA,San Francisco,94107

    获取路线

Revel Pharmaceuticals员工

相似主页

查看职位

融资